Gut microbiota may mediate the causality of statins on diabetic nephropathy: a mediation Mendelian randomization study

Xu, Gaosi

DOI: https://doi.org/10.1007/s11255-024-04321-0

IF: 2.2662

2024-12-11

International Urology and Nephrology

Abstract:Increasing evidence indicates that statins may increase the risk of developing diabetic nephropathy (DN). As the gut–kidney axis concept gains traction, it remains unclear whether statins contribute to the onset and progression of DN by modulating gut microbiota.

urology & nephrology